SOURCE: StockCall

StockCall

May 25, 2012 08:20 ET

Equity Research on AmerisourceBergen Corporation and Omnicare Inc. - Drug Wholesalers Target Expansion

JOHANNESBURG, SOUTH AFRICA--(Marketwire - May 25, 2012) - www.stockcall.com/ offers investors comprehensive research on the Drugs Wholesale industry and has completed analytical research on AmerisourceBergen Corporation (NYSE: ABC) and Omnicare Inc. (NYSE: OCR). Register with us today at www.stockcall.com/ to have free access to these researches.

Drug wholesalers have performed well as a whole through the first five months of the year. As a result, several companies have become increasingly growth minded and have upped their international expansion and acquisition efforts. Register now at https://stockcall.com/development/stockcall/page.php?name=register.html to have free access to our reports on the Drugs Wholesale industry.

www.stockcall.com/ is an online platform where investors doing their due-diligence on the Drugs Wholesale industry can have easy and free access to our analyst research and opinions on AmerisourceBergen Corporation and Omnicare Inc.; investors and shareholders of these companies can simply register for a complimentary membership at https://stockcall.com/development/stockcall/page.php?name=register.html.

AmerisourceBergen Corp., one of the world's largest drug wholesalers, is ambitiously looking to boost its international profits from 4% to 20% in the next decade. The company is off to a strong start following the $520 million purchase of World Courier Group earlier this month. AmerisourceBergen Corporation research report is accessible for free by registering today at www.stockcall.com/ABC250512.pdf.

Omnicare Inc., a drug provider to long-term care facilities, also looks well positioned to widen margins this year coming off a first quarter in which sales climbed 4.4% over the prior year period. The wholesaler did hit a speed bump when it agreed to pay $50 million to the federal government to settle claims that it improperly dispensed controlled substances at long-term care facilities. First quarter momentum appears strong enough to offset the effects of this fine though. Omnicare Inc. research report is available for free by signing up now at www.stockcall.com/OCR250512.pdf.

Visit www.stockcall.com/ to see how companies in this industry have grown over the past years and how they are expected to perform in the future.

About StockCall.com
StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines.

Contact Information